305 related articles for article (PubMed ID: 15199484)
1. Targeting tissue factor as an antithrombotic strategy.
Golino P; Cimmino G
Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
[TBL] [Abstract][Full Text] [Related]
2. The inhibitors of the tissue factor:factor VII pathway.
Golino P
Thromb Res; 2002 May; 106(3):V257-65. PubMed ID: 12356487
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the tissue factor coagulation pathway.
Golino P; Forte L; De Rosa S
Curr Vasc Pharmacol; 2004 Oct; 2(4):319-27. PubMed ID: 15320811
[TBL] [Abstract][Full Text] [Related]
4. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
Del Turco S; De Caterina R
Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
[TBL] [Abstract][Full Text] [Related]
5. [The role of tissue factor and its inhibitor in hemostasis].
Naumnik B; Małyszko J; Myśliwiec M
Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
[TBL] [Abstract][Full Text] [Related]
6. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
7. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the procoagulant response to arterial injury.
Taubman MB; Giesen PL; Schecter AD; Nemerson Y
Thromb Haemost; 1999 Aug; 82(2):801-5. PubMed ID: 10605785
[TBL] [Abstract][Full Text] [Related]
9. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?
Versteeg HH; Peppelenbosch MP; Spek CA
Thromb Haemost; 2001 Dec; 86(6):1353-9. PubMed ID: 11776298
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor - a therapeutic target for thrombotic disorders.
Houston DS
Expert Opin Ther Targets; 2002 Apr; 6(2):159-74. PubMed ID: 12223078
[TBL] [Abstract][Full Text] [Related]
11. Relevance of tissue factor in cardiovascular disease.
Jude B; Zawadzki C; Susen S; Corseaux D
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
Himber J; Kirchhofer D; Riederer M; Tschopp TB; Steiner B; Roux SP
Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.
Steffel J; Lüscher TF; Tanner FC
Circulation; 2006 Feb; 113(5):722-31. PubMed ID: 16461845
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor in health and disease.
Semeraro N; Colucci M
Thromb Haemost; 1997 Jul; 78(1):759-64. PubMed ID: 9198252
[TBL] [Abstract][Full Text] [Related]
16. Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
Szalony JA; Suleymanov OD; Salyers AK; Panzer-Knodle SG; Blom JD; LaChance RM; Case BL; Parlow JJ; South MS; Wood RS; Nicholson NS
Thromb Res; 2003; 112(3):167-74. PubMed ID: 14967414
[TBL] [Abstract][Full Text] [Related]
17. Cytokines and hemostasis.
Grignani G; Maiolo A
Haematologica; 2000 Sep; 85(9):967-72. PubMed ID: 10980636
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
Chu AJ
Cell Biochem Funct; 2006; 24(2):173-92. PubMed ID: 15617024
[TBL] [Abstract][Full Text] [Related]
19. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention.
Holy EW; Tanner FC
Adv Pharmacol; 2010; 59():259-92. PubMed ID: 20933205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
